Last Updated on July 21, 2024 by The Health Master
USFDA Inspection
Zydus Lifesciences Limited, a leading Indian pharmaceutical company, is pleased to announce a successful outcome following a recent USFDA inspection by the US Food and Drug Administration (USFDA) at its transdermal manufacturing facility located at the Ahmedabad SEZ.
This positive development comes after previous observations from the USFDA at a separate Zydus Lifesciences facility, the SEZ Onco Injectable manufacturing plant, which the company is actively addressing.
Focused USFDA Inspection
The USFDA inspection at the transdermal facility focused on evaluating the company’s manufacturing processes, data integrity, and quality control procedures for transdermal drug products.
Zydus Lifesciences successfully demonstrated its adherence to stringent USFDA regulations, resulting in a favorable outcome at the closure of the USFDA inspection.
Maintaining High Quality Standards
“At Zydus Lifesciences, we are committed to maintaining the highest quality standards in all aspects of our operations,” said Zydus Lifesciences in a statement.
“We are pleased with the outcome of the USFDA inspection at our transdermal facility and remain dedicated to providing patients with safe and effective transdermal medications.”
About Zydus Lifesciences
Zydus Lifesciences Limited, headquartered in Ahmedabad, India, is a leading global lifesciences company.
The company discovers, develops, manufactures, and markets a broad portfolio of healthcare therapies, with a significant presence in the critical area of cancer-related treatments.
Zydus Lifesciences offers a comprehensive range of solutions, including cytotoxic, supportive, and targeted drugs, to address various oncological needs.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
USFDA inspection concluded at Divi’s Labs with one observation
USFDA issues positive EIR to Lupin Limited at Gujarat
USFDA grants VAI classification to Cipla at Maharashtra
USFDA inspection concluded with positive report at Alkem
USFDA issues positive EIR to Lupin Limited
USFDA approval granted for Topiramate Capsules USP
USFDA declines to approve this Nasal Spray
USFDA inspection concluded at Divi’s Labs with one observation
Yoga may be beneficial in Rheumatoid Arthritis: AIIMS study
HM Calls for Transparent CDSCO to Ensure Quality
USFDA approval granted for the drug used for Colon Cleansing
USFDA issues positive EIR to Lupin Limited at Gujarat
Drug Rules to include excipient details in drug labels
USFDA approval granted for the drug for the treatment of Migraine
USFDA grants VAI classification to Cipla at Maharashtra
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
